Evidence map›Paper›PMID 31287879›Full record

ArticleThe Journal of infectious diseases2019

Specific Vaginal Bacteria Are Associated With an Increased Risk of Trichomonas vaginalis Acquisition in Women.

Olamide D Jarrett, Sujatha Srinivasan, Barbra A Richardson, Tina Fiedler, Jacqueline M Wallis, John Kinuthia, Walter Jaoko, Kishor Mandaliya, David N Fredricks, R Scott McClelland

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Modulation of group BInfection and immunity · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Evolutionary conservation ofFrontiers in microbiology · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  15. Review
  16. Article
  17. Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Olamide D JarrettDivision of Infectious Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Sujatha SrinivasanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Barbra A RichardsonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Tina FiedlerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Jacqueline M WallisVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
John KinuthiaKenyatta National Hospital, University of Nairobi, Nairobi, Kenya.
Walter JaokoDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Kishor MandaliyaDepartment of Global Health, University of Washington, Seattle, Washington.
David N FredricksVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
R Scott McClellandDepartment of Epidemiology, University of Washington, Seattle, Washington.
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAUniversity of Nairobi · KEUniversity of Illinois Chicago · USUniversity of Washington · US

Funding

Relationship between vaginal micobiota and T. vaginalis acquisitionK23HD069570 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JARRETT, OLAMIDE DAPHNA · 2012 to 2014
$365k
NICHD NIH HHS K23 HD069570
6 · The paper itself

Abstract

backgroundWhile bacterial vaginosis has been associated with an increased risk of Trichomonas vaginalis (TV) acquisition, it is unknown whether other characteristics of the vaginal microbiota, including the presence of key bacterial species, influence a woman's risk of TV acquisition.

methodsThe vaginal microbiota before 25 unique episodes of TV infection involving 18 women was compared to that of 50 controls who remained uninfected. TV was detected by transcription-mediated amplification. Vaginal microbiota were quantified using broad-range polymerase chain reaction analysis and taxon-specific quantitative PCR of the 16S ribosomal RNA gene.

resultsTV acquisition was significantly associated with the presence of Prevotella amnii (risk ratio [RR], 2.21; 95% confidence interval [CI], 1.12-4.38; P = .02) and Sneathia sanguinegens (RR, 2.58; 95% CI, 1.00-6.62; P = .049). When adjusted for menstrual phase, the association between P. amnii and TV acquisition remained similar (adjusted RR, 2.11; 95% CI, 1.03-4.33; P = .04), but the association between S. sanguinegens and TV acquisition was attenuated (adjusted RR, 2.31; 95% CI, .86-6.23; P = .10).

conclusionsKey vaginal bacterial species may contribute to the susceptibility to TV acquisition. Understanding how these bacterial species increase a woman's risk of TV acquisition could help to guide the development of novel strategies to reduce women's risk of TV infection.

Indexed as

BiotaDisease SusceptibilityAdultBacteriaDNA, BacterialDNA, ProtozoanFemaleHumansMiddle AgedNucleic Acid Amplification TechniquesProspective StudiesRisk AssessmentTrichomonas vaginalisTrichomonas VaginitisVaginaDNA, BacterialDNA, Protozoanbacterial diversitypolymerase chain reactionTrichomonas vaginalisvaginal microbiome

Identifiers

PMID31287879
PMCPMC6761949
OpenAlexW2960589487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.